Kynos Therapeutics
Latest round
- Series A
Last raised
- Feb 2022
Total raised
- $8.8M
Investors
- 3
About Kynos Therapeutics
, aka Kynos is a biotechnology company engaged in the development of KMO inhibitors. The company is a spin-out from the University of Edinburgh and was co-founded by its CEO, Damian Mole, and Chief Scientific Officer, Scott Webster. Kynos develops a pipeline of KMO (kynurenine 3-monooxygenase) inhibitors that can target KMO, an enzyme that regulates inflammation, as well as the way inflammation and metabolism control the immune system. The company’s programs are focused on enhancing the medical outcomes in three key areas including critical illness or post-surgery illness, conditions driven by inflammation (ex: endometriosis), and cancers where inflammation negatively impacts the functionality of the immune system.
Who invested in Kynos Therapeutics
3 investors across 1 round
See all investors in Kynos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 3, 2022
Amount
$8.8M
Investors
Questions about Kynos Therapeutics
Who invested in Kynos Therapeutics?
Kynos Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kynos Therapeutics raised?
Kynos Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kynos Therapeutics last raise money?
Kynos Therapeutics's most recent round on record is a Series A, in Feb 2022.
What does Kynos Therapeutics do?
, aka Kynos is a biotechnology company engaged in the development of KMO inhibitors.
Where is Kynos Therapeutics headquartered?
Kynos Therapeutics is headquartered in Sheffield, UK.
Which VCs invest in companies like Kynos Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Kynos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kynos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.